Cell based assays: novel technologies in cell based assay platforms, 18-19 November 2013, London, UK

Date: Sep-18-2013Following on from its hugely successful Cell-Based Assays conference in 2012, this year's event, taking place on the 18th-19th of November 2013 in London, UK, will feature over 16 innovative presentations delivered by some of the leading names in the Pharma industry, discussing 3D cell culture, future screening tools and primary phenotypic assays, drug design, targeting ION channels and novel technologies in the latest Cell Based Assays platforms.

According to event's chairman Dr. Anthony Davies, Director of the High Content Facility, Institute of Molecular Medicine, Trinity College Dublin, "The SMi's Cell Based Assays conference agenda is both fresh and comprehensive covering many of the most interesting and important topics areas in this scientific field. In my opinion, anyone working with cell based assays would benefit from attending this meeting." Dr. Davies will also host an interactive half-day post-conference workshop "Overcoming the challenges of moving from 2D to 3D Cell Based Assays in an HCS and HTS environment".

Event's highlights include:
Hear the latest on Phenotypic screening; how target based screening is allowing for identification of small molecules
See how you can implement a primary cell assay plan through a case study of SAR-driving assay
The latest in GPCR and other ion channel targeting pathways and how they are being used in the most recent drug discovery assays
Adopt accelerated primary cell screening systems such as those utilised by GSK

Keynote speakers include:

Mao Xiang Chen, Biological and Cellular targets, GlaxoSmithKline
Martha Brown, Senior Associate Director, Boehringer-Ingelheim
Xavier Leroy, Director, Actelion
Steve Ludbrook, Section Head, GlaxoSmithKline
Urs Luethi, Senior Lab Head Discovery, Actelion
Tyrell Norris, Team Leader - Cellular Reagents & Assay Development, AstraZeneca
Amir Gander, Senior Knowledge Transfer Associate, University College London

2013 attendees include leading experts from GlaxoSmithKline, Actelion, Imagen Biotech, AstraZeneca, Actelion, Novartis, Imperial College London and many others.

For the full conference programme and further information please click here.

Alternatively contact Fateja Begum on +44 (0)20 7827 6184 or email: fbegum@smi-online.co.uk

Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.